Maintaining Cognitive Function in Patients with CNS Metastases Receiving Multimodality Treatment
|
|
- Shon Riley
- 6 years ago
- Views:
Transcription
1 Maintaining Cognitive Function in Patients with CNS Metastases Receiving Multimodality Treatment Jeffrey S. Wefel, PhD, ABPP Section Chief and Associate Professor Section of Neuropsychology Department of Neuro-Oncology and Department of Radiation Oncology
2 Objectives Review cognitive dysfunction in patients with brain mets Highlight approaches to the clinical management of cognitive dysfunction Introduce emerging preclinical-translational cognitive science
3 Brain Metastasis Overall incidence >10-16% (lung, breast, melanoma) >170,000/year in USA Challenges related to maintaining cognitive function Disease and treatment = cognitive dysfunction Efficacy / Toxicity balance ( Therapeutic window ) Limited treatments to protect or restore cognitive function Improved OS NSCLC Breast Melanoma Sperduto, JCO, 2012; Nayak et al, Curr Neurol Rep, 2012
4 Brain Mets Cognitive Dysfunction Tumor Effects patients with brain mets are cognitively impaired at the time of diagnosis (>90%) cognitive function correlates with lesion volume (r= , p<0.0001) not number of mets NCF Test Multiple % Impaired (N=401) Single % Impaired (N=80) 0 Impaired 9 36 >1 Impaired >4 Impaired MEMORY HVLT-R TR PROCESSING SPEED TMT A EXECUTIVE FUNCTION TMT B COWA FINE MOTOR CONTROL Dominant Hand Nondominant Hand Meyers et al., JCO, 2004; Wefel, unpublished
5 Multimodality Treatment management Strategies Goal: Control brain disease without toxicity, and extend life while preserving function/qol Treatment Approach Surgery Radiation Chemotherapy Immunotherapy Optune (TTF) Combinations of the above Challenges Residual disease Inaccessible tumor Dose constraints location Off target tox (cognitive decline) BBB, branched evolution, chemobrain Neurotoxicity -seizure -inflammation -CRS, AMS Potential Solutions -Fluorescence -LITT -Brachytherapy, improved targeting -SRS, WBRT sparing techniques -Sensitizers? -Targeted therapy -? symptom management? -METIS trial (SRS+/-TTF in NSCLC) -Patient tolerance -Risk adapted therapy Adapted from Hardesty & Nakaji, Front Surg, 2016
6 Maximizing Cognitive Function Prevent cognitive decline Technological SRS +/- WBRT (MDACC ID00-377, NCCTG N0574) HA-WBRT (RTOG 0933) Pharmacological Neuroprotection (RTOG 0614) Targeted approaches, immunotherapies Manage cognitive deficits Comorbidities Reversible contributors Maintain Brain Health Pharmacological Stimulants Pro-cognitive medications Behavioral Neuroplasticity-based training? Compensatory strategies Preclinical-Translational Next Gen Frontier
7 Preventing Cognitive Decline Technological SRS +/- WBRT for 1-3 mets (MDACC ID00-377, NCCTG N0574) Chang et al., Lancet Oncol, 2009
8 Preventing Cognitive Decline Technological SRS +/- WBRT for 1-3 mets (MDACC ID00-377, NCCTG N0574) Chang et al., Lancet Oncol, 2009; Brown et al., JAMA 2017
9 Preventing Cognitive Decline Technological SRS +/- WBRT for 1-3 mets (MDACC ID00-377, NCCTG N0574) HA-WBRT (RTOG 0933) HA-WBRT decline at 4 months = 7% vs 30% (hxl cntl) Chang et al., Lancet Oncol, 2009; Brown et al., JAMA 2017; Gondi et al., JCO, 2014
10 Preventing Cognitive Decline Pharmacological Neuroprotection (RTOG 0614) N=508 eligible Stratify: -RPA Class* -Prior Surgery** 20mg Memantine Daily x 24 weeks WBRT: 37.5 Gy (15 Fx of 2.5 Gy) Placebo Daily x 24 weeks Cognitive Function Failure (%) Failures Total p (one-sided) = HR= (0.621, 0.988) Patients at Risk Memantine Placebo Months from Randomization Memantine Placebo Memantine increased time to cognitive decline, HR=0.78, p= Brown et al., Neuro-Onc, 2013
11 Preventing Cognitive Decline Pharmacological Neuroprotection (RTOG 0614) N=508 eligible Stratify: -RPA Class* -Prior Surgery** WBRT: 37.5 Gy (15 Fx of 2.5 Gy) Placebo Daily x 24 weeks Technological +/- Pharmacological NRG CC001: A Randomized Phase III Trial of Memantine +/- Hippocampal Avoidance in Patients with Brain Metastases Brain mets Stratify: -RPA Class -Prior Therapy WBRT + Memantine HA-WBRT + Memantine Primary: Time to cognitive failure 20mg Memantine Daily x 24 weeks NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer SCLC Cognitive Function Failure (%) Patients at Risk Memantine Placebo Stratify: -Stage -Age -Planned Memantine Failures Total p (one-sided) = HR= (0.621, 0.988) Months from Randomization PCI (25Gy x 10) HA-PCI (25Gy x 10) Primary Ph II intracranial relapse rate, non-inferiority Primary Ph III HVLT-R DR decline at 6 months, efficacy Memantine Placebo Memantine increased time to cognitive decline, HR=0.78, p=
12 Maximizing Cognitive Function Prevent cognitive decline Technological SRS +/- WBRT (MDACC ID00-377, NCCTG N0574) HA-WBRT (RTOG 0933) Pharmacological Neuroprotection (RTOG 0614) Targeted approaches, immunotherapies Manage cognitive deficits Comorbidities Reversible contributors Maintain Brain Health Pharmacological Stimulants (fatigue, attention, processing speed) Donepezil Behavioral Neuroplasticity-based training? Compensatory strategies Preclinical-Translational Next Gen Frontier
13 Address Reversible Contributors Metabolic abnormalities Thyroid abnormality Electrolyte abnormality Glucose abnormality Vitamin deficiencies Cushing s disease Addison s disease Organ failure (liver, renal, respiratory) Medication side effects Anti-cholinergics, pain meds Mood disturbance Seizures Edema Substance use/abuse Poor adherence to medication schedule due to cognitive dysfunction Pill box, alarms, caregiver support
14 Maintaining Brain Health Stay Connected Get Moving -Aerobic: 150 minutes moderate / 75 minutes vigorous -Strength: 2x/week Eat Smart Keep Sharp Control Risks Rest Well Cleveland Clinic, Healthy Brains
15 Physical Activity Physical Activity -more new neurons -proper orientation
16 Maintaining Brain Health Stay Connected Get Moving -Aerobic: 150 minutes moderate / 75 minutes vigorous -Strength: 2x/week Eat Smart Keep Sharp -Stay mentally active -Remain curious -Learn new hobby, skill -Play: engage your brain Rest Well Control Risks Cleveland Clinic, Healthy Brains
17 Cognitive Stimulation Environmental Enrichment -more hippocampal neurons -improved memory
18 Maintaining Brain Health Stay Connected -Social support -Insulates against stress -Stimulating conversation Get Moving -Aerobic: 150 minutes moderate / 75 minutes vigorous -Strength: 2x/week Eat Smart **Dietician -Low-carb diet -Mediterranean diet -Avoid: saturated fat, trans fat, added sugars Keep Sharp -Stay mentally active -Remain curious -Learn new hobby, skill -Play: engage your brain Rest Well -7-9 hours sleep -Manage stress Control Risks -Blood pressure -Cholesterol -Avoid smoking -Moderate alcohol intake Cleveland Clinic, Healthy Brains
19 Pharmacological: Stimulants Fatigue and Cognition -no beneficial effect on fatigue (nor depression, HRQOL, cognitive function) -modest beneficial effect on fatigue -beneficial effects on hypoactive delirium in advanced cancer patients (Gagnon, 2005) Gagnon et al., J Psychiatry Neurosci, 2005
20 Pharmacological: CBT vs Armodafinil Fatigue and Sleep Disturbance Path diagram for a Structural Equation Model (red lines are statistically significant). CBT impacts fatigue through reduction in insomnia severity. Heckler et al., Support Care Cancer, 2016
21 Pharmacological: Donepezil after Radiation (> 6 mos) N= 198 (26% attrition at 24 weeks), 25% brain mets 24 weeks of donepezil (5mg for 6 weeks, 10mg for 18 weeks) or placebo After 24 weeks there was no difference between placebo and donepezil in the amount of change on the composite cognitive function variable or 13/16 other cognitive test scores Exploratory subgroup analysis suggested better effects in individuals with greater cognitive dysfunction prior to treatment
22 Behavioral: Cognitive Rehabilitation Goal: reduce the interference of cognitive inefficiencies on everyday life Compensatory Strategy Training Utilize preserved skills to support areas of cognitive weakness Use visual memory capacity to support verbal memory disorder Mnemonics, chunking, elaborative rehearsal, spaced retrieval Minimize distractions Cognitive prostheses Memory prosthesis - Smart phone (calendar, alarms, etc) Environmental modifications Psychotherapy and psychoeducation Improve coping, stress management Brain injury and functional impact Identify high risk situations, anticipate and plan Reviews: Cicerone et al, APMR, 2005; Gehring et al., Expert Rev, 2010
23 Behavioral: Computerized Training evidence that brain-training interventions improve performance on the trained tasks, less evidence that such interventions improve performance on closely related tasks, and little evidence that training enhances performance on distantly related tasks or that training improves everyday cognitive performance.
24 Pathogenesis of Radiation Damage Neurodegenerative processes initiated very early Vascular endothelial damage Inflammation and microglial dysregulation Oligodendrocyte injury Neuronal damage and altered neurogenesis Epigenetic aberrations
25 Preclinical Translational Opportunities Mesenchymal stem cells Cisplatin 2.3 mg/kg 5 daily injections Cisplatin 2.3 mg/kg 5 daily injections Intranasal MSC 1x10 66 Cognition Brain damage Days Intranasal MSC for cisplatin cognitive impairment D is c rim in a tio n in d e x * * S a lin e M S C C is p la tin C is p la tin + M S C Courtesy of Cobi Heijnen, PhD
26 Preclinical Translational Cognitive Lab
27 Merci!
The Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationMinesh Mehta, Northwestern University. Chicago, IL
* Minesh Mehta, Northwestern University Chicago, IL Consultant: Adnexus, Bayer, Merck, Tomotherapy Stock Options: Colby, Pharmacyclics, Procertus, Stemina, Tomotherapy Board of Directors: Pharmacyclics
More informationOptimal Management of Isolated HER2+ve Brain Metastases
Optimal Management of Isolated HER2+ve Brain Metastases Eliot Sims November 2013 Background Her2+ve patients 15% of all breast cancer Even with adjuvant trastuzumab 10-15% relapse Trastuzumab does not
More informationCancer and Cognitive Functioning: Strategies for Improvement
Cancer and Cognitive Functioning: Strategies for Improvement Myron Goldberg, Ph.D., ABPP-CN Clinical Neuropsychologist Director, Neuro-Rehabilitation Program Department of Rehabilitation Medicine University
More informationAlleinige Radiochirurgie und alleinige Systemtherapie zwei «extreme» Entwicklungen in der Behandlung von Hirnmetastasen?
Department of Radiation Oncology Chairman: Prof. Dr. Matthias Guckenberger Alleinige Radiochirurgie und alleinige Systemtherapie zwei «extreme» Entwicklungen in der Behandlung von Hirnmetastasen? Matthias
More informationCancer and Cognitive Functioning
Cancer and Cognitive Functioning Myron Goldberg, PhD, ABPP-CN Clinical Neuropsychologist Department of Rehabilitation Medicine University of Washington Medical Center Cognitive Functioning after Cancer
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Management of Brain Metastases Dr. Luis Souhami Professor Department of Radiation Oncology University,
More informationInnova&ve Trial Concepts for Brain Metastases. Minesh P Mehta, MD, FASTRO Professor, University of Maryland
Innova&ve Trial Concepts for Brain Metastases Minesh P Mehta, MD, FASTRO Professor, University of Maryland Historic Trial Design A common theme has been to design an all inclusive trial that includes Most
More informationNeuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory
Neuropsychology and Parkinson s Disease Erin Holker, Ph.D., ABPP Neuropsychology Laboratory Parkinson s disease and cognition Parkinson s disease is not just a disorder of movement The same circuits associated
More informationMehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey
Updated Oncology 2015: State of the Art News & Challenging Topics CURRENT STATUS OF STEREOTACTIC RADIOSURGERY IN BRAIN METASTASES Mehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey Bucharest,
More informationProphylactic Cranial Irradiation and Thoracic Radiotherapy in Extensive Stage Small-Cell Lung Cancer
Prophylactic Cranial Irradiation and Thoracic Radiotherapy in Extensive Stage Small-Cell Lung Cancer Dr Neil Bayman Consultant Clinical Oncology ESMO-Christie Preceptorship Programme in Lung Cancer, March
More informationNRG ONCOLOGY NRG-CC003
NRG ONCOLOGY NRG-CC003 A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer SCHEMA Histologic proof or unequivocal cytologic
More informationRole of Prophylactic Cranial Irradiation in Small Cell Lung Cancer
Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer Kazi S. Manir MD,DNB,ECMO,PDCR Clinical Tutor Department of Radiotherapy R. G. Kar Medical College and Hospital, Kolkata SCLC 15% of lung
More informationARROCase Brain Metastases
ARROCase Brain Metastases Colin Hill*, Daniel M. Trifiletti*, Timothy N. Showalter*, Jason P. Sheehan Radiation Oncology* and Neurosurgery University of Virginia Charlottesville, VA Case: HPI 64 year old
More informationTreating Brain Metastases in the Changing World of Oncology: Matthew Ewend, MD Kay and Van Weatherspoon Professor Chair, Department of Neurosurgery
Treating Brain Metastases in the Changing World of Oncology: Matthew Ewend, MD Kay and Van Weatherspoon Professor Chair, Department of Neurosurgery Disclosures Consultant: None Stock Holdings: None Paid
More informationRadiotherapy and Brain Metastases. Dr. K Van Beek Radiation-Oncologist BSMO annual Meeting Diegem
Radiotherapy and Brain Metastases Dr. K Van Beek Radiation-Oncologist BSMO annual Meeting Diegem 24-02-2017 Possible strategies Watchful waiting Surgery Postop RT to resection cavity or WBRT postop SRS
More informationCécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010
Prophylactic Cranial Irradiation in Lung Cancer Cécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010 Prophylactic cranial irradiation PCI was introduced
More informationStereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms. Overall Clinical Significance 8/3/13
Stereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms Jason Sheehan, MD, PhD Departments of Neurosurgery and Radiation Oncology University of Virginia, Charlottesville, VA USA Overall
More informationNon-uniform dose distributions in whole brain radiotherapy
Non-uniform dose distributions in whole brain radiotherapy Edward T. Bender April 23, 2010 Under the supervision of: Dr. Wolfgang Tomé Outline Background Information Whole brain radiotherapy and small
More informationParallel Session 9.1: Late effects
Parallel Session 9.1: Late effects Sanne Schagen: Effects of chemotherapy on cognition and brain structure in pts with non-cns disease Olga Husson: Health-related quality of life and disease specific symptoms
More informationCombined treatment of Brain metastases: Radiosurgery and Targeted therapy
Combined treatment of Brain metastases: Radiosurgery and Targeted therapy Stephanie Kroeze, MD PhD OVERVIEW Introduction brain metastases Targeted therapy as monotherapy Efficacy of SRS combined with Targeted
More informationBrain metastases and meningitis carcinomatosa: Prof. Rafal Dziadziuszko Medical University of Gdańsk, Poland
Brain metastases and meningitis carcinomatosa: a palliative situation? Prof. Rafal Dziadziuszko Medical University of Gdańsk, Poland SAMO, Lucerne, February 1-2, 2013 Treatment options for NSCLC patients
More informationBrain metastases are detected in approximately 20%
COUNTERPOINTS Current Controversies in Hematology and Oncology Should All Patients With SCLC Receive Prophylactic Cranial Irradiation If They Have Responded to Treatment? Brain metastases are common in
More informationTargeted/Immunotherapy & Molecular Profiling State-of-the-art in Cancer Care
Targeted/Immunotherapy & Molecular Profiling State-of-the-art in Cancer Care Manmeet Ahluwalia, MD, FACP Miller Family Endowed Chair in Neuro-Oncology Director Brain Metastasis Research Program Cleveland
More informationSociety for Immunotherapy of Cancer (SITC) Immunotherapy for the Treatment of Brain Metastases
Society for Immunotherapy of Cancer (SITC) Immunotherapy for the Treatment of Brain Metastases Geoffrey T. Gibney, MD Georgetown-Lombardi Comprehensive Cancer Center Medstar-Georgetown University Hospital
More informationManagement of Brain Metastases Sanjiv S. Agarwala, MD
Management of Brain Metastases Sanjiv S. Agarwala, MD Professor of Medicine Temple University School of Medicine Chief, Oncology & Hematology St. Luke s Cancer Center, Bethlehem, PA, USA Incidence (US):
More informationMetastasi cerebrali La Radioterapia: tecnica, frazionamento, radiosensibilizzanti
Metastasi cerebrali La Radioterapia: tecnica, frazionamento, radiosensibilizzanti Brain Metastases Radiation Therapy of multiple brain metastases Is treatment appropriate? - Survival - QoL Brain Metastases
More informationIAN CROCKER = TIM HOWARD
Winship Cancer Institute of Emory University Radiation as Consolidation in the Treatment of Newly Diagnosed CNS Lymphoma versus After Failure of Chemotherapy Pro: Upfront Radiation Ian Crocker MD, FACR,
More informationSelecting the Optimal Treatment for Brain Metastases
Selecting the Optimal Treatment for Brain Metastases Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Understand the benefits, limitations,
More informationInterventions for cognitive deficits in patients with a brain tumor Gehring, Karin; Aaronson, N.K.; Taphoorn, M.J.B.; Sitskoorn, Margriet
Tilburg University Interventions for deficits in patients with a brain tumor Gehring, Karin; Aaronson, N.K.; Taphoorn, M.J.B.; Sitskoorn, Margriet Published in: Expert Review of Anticancer Therapy Document
More informationRTOG Lung Cancer Committee 2012 Clinical Trial Update. Wally Curran RTOG Group Chairman
RTOG Lung Cancer Committee 2012 Clinical Trial Update Wally Curran RTOG Group Chairman 1 RTOG Lung Committee: Active Trials Small Cell Lung Cancer Limited Stage (Intergroup Trial) Extensive Stage (RTOG
More informationUpdate on Limited Small Cell Lung Cancer. Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver
Update on Limited Small Cell Lung Cancer Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver Objectives - Limited Radiation Dose Radiation Timing Radiation Volume PCI Neurotoxicity
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM BRAIN METASTASES CNS Site Group Brain Metastases Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationUpdate on management of metastatic brain disease. Peter Hoskin Mount Vernon Cancer Centre Northwood UK
Update on management of metastatic brain disease Peter Hoskin Mount Vernon Cancer Centre Northwood UK Incidence 15-30% of patients with solid tumours will develop brain metastases Most common primary sites
More informationHong Kong Hospital Authority Convention 2018
Hong Kong Hospital Authority Convention 2018 Stereotactic Radiosurgery in Brain Metastases - Development of the New Treatment Paradigm in HA, Patients Profiles and Their Clinical Outcomes 8 May 2018 Dr
More informationUnderstanding Cancer-related Cognitive Impairment
Understanding Cancer-related Cognitive Impairment Tracy D. Vannorsdall, PhD, ABPP/CN Assistant Professor Division of Medical Psychology 5/31/2016 1 Agenda Types of cognitive problems experience What the
More informationRadiation-induced changes in brain function after cranial irradiation: Radiobiology and clinical review
Radiation-induced changes in brain function after cranial irradiation: Radiobiology and clinical review Brian Marples PhD Beaumont Health System Royal Oak, Michigan Disclosures Radiobiologist Department
More informationProtocolos de consenso: MTS Cerebrales Resumen ASTRO. Javier Aristu y Germán Valtueña Servicio Oncología Rad. Depart.
Protocolos de consenso: MTS Cerebrales Resumen ASTRO Javier Aristu y Germán Valtueña Servicio Oncología Rad. Depart. ASTRO 2013 Brain met SRS Abstracts 97. Comparative Effectiveness of SRS versus WBRT
More informationBrain metastases: changing visions
Brain metastases: changing visions Roberto Spiegelmann, MD Baiona, 2014 Head, Stereotactic Radiosurgery Unit Dept of Neurosurgery, Chaim Sheba Medical Center Tel Hashomer, Israel The best current estimate
More informationES-SCLC Joint Case Conference. Anthony Paravati Adam Yock
ES-SCLC Joint Case Conference Anthony Paravati Adam Yock Case 57 yo woman with 35 pack year smoking history presented with persistent cough and rash Chest x-ray showed a large left upper lobe/left hilar
More informationOverview: Immunotherapy in CNS Metastases
Overview: Immunotherapy in CNS Metastases Manmeet Ahluwalia, MD, FACP Miller Family Endowed Chair in Neuro-Oncology Director Brain Metastasis Research Program Cleveland Clinic Disclosures Consultant- Monteris
More informationCONTINUING PROFESSIONAL DEVELOPMENT
23/09/15 POSTGRADUATE SCHOOL OF MEDICINE BRAIN METASTASES Prof M Brada and Dr John Green MDSC156/199: Acute Clinical Oncology A MEMBER OF THE RUSSELL GROUP CONTINUING PROFESSIONAL DEVELOPMENT Brain Metastases
More informationTreatment of Recurrent Brain Metastases
Treatment of Recurrent Brain Metastases Penny K. Sneed, M.D. Dept. of Radiation Oncology University of California San Francisco Background Brain metastases occur in 8.5-15% of cancer pts in population-
More informationLung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We
Lung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We Edward Garon, MD, MS Associate Professor Director- Thoracic Oncology Program David
More informationPalliative radiotherapy in lung cancer
New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer
More informationSpecial Situation: Brain metastases
ESMO Advanced Course on Unsolved Questions in Immuno-Oncology February 16-17 2018, Amsterdam, Netherlands Special Situation: Brain metastases Matthias Preusser, MD Associate Professor of Medicine Department
More informationNeurocognitive Impairments in HIV: Natural History, Impacts on Everyday Functioning and Promising Interventions
Neurocognitive Impairments in HIV: Natural History, Impacts on Everyday Functioning and Promising Interventions Sean B. Rourke, Ph.D. Scientist and Neuropsychologist, St. Michael s Hospital Director, CIHR
More informationAlzheimer s Disease Update: From Treatment to Prevention
Alzheimer s Disease Update: From Treatment to Prevention Jeffrey M. Burns, MD Edward H. Hashinger Professor of Medicine Co-Director, KU Alzheimer s Disease Center Director, Clinical and Translational Science
More information9/29/2017. Disclosures. Objectives. Cancer-Related Cognitive Dysfunction (CRCD)
Cancer Related Cognitive Dysfunction (CRCD): Diagnosis, Pathophysiology and Management Disclosures No conflict of interest disclosures M. Beatriz Currier, MD John M Cassel Memorial Breast Cancer Symposium
More informationTania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015
Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015 Most common brain tumor, affecting 8.5-15% of cancer patients. Treatment options: Whole brain radiation
More informationRadiotherapy for Brain Metastases
Radiotherapy for Brain Metastases Robert B. Den, MD a, David W. Andrews, MD b, * KEYWORDS Brain metastases Treatment approaches SRS WBRT The optimal treatment of brain metastases remains controversial.
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationAfter the Diagnosis: Rehabilitation & Support Options for Mild Dementia
After the Diagnosis: Rehabilitation & Support Options for Mild Dementia Dr. Toni Nicholls, Clinical Neuropsychologist Peronne Village, cottage #20, Worthing, Christ Church 621-2022 Say these aloud Dog
More informationWhy am I so Tired? Cancer Related Fatigue. Rose Bell, PhD, ARNP, AOCNP Northwest Medical Specialties
Why am I so Tired? Cancer Related Fatigue Rose Bell, PhD, ARNP, AOCNP Northwest Medical Specialties Cancer Related Fatigue (CRF) Significantly different in quality and severity Unrelieved by sleep or rest
More informationHypofractionated RT in Cervix Cancer. Anuja Jhingran, MD
Hypofractionated RT in Cervix Cancer Anuja Jhingran, MD Hypofractionated RT in Cervix Cancer: Clinicaltrials.gov 919 cervix trials 134 hypofractionated RT trials Prostate, breast, NSCLC, GBM 0 cervix trials
More informationTrimodality Therapy for Muscle Invasive Bladder Cancer
Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,
More informationChemo Fog: What it is and what can we do about it
Chemo Fog: What it is and what can we do about it Lori Bernstein, Ph.D., C.Psych. Dept of Psychosocial Oncology & Palliative Care & Cancer Survivorship Program Health, Wellness, and Cancer Survivorship
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationChemo Brain : What We Know and What We Need to Learn
Chemo Brain : What We Know and What We Need to Learn Rachel Isaksson Vogel, Ph.D. Assistant Professor Department of Obstetrics, Gynecology and Women s Health Masonic Cancer Center s Women s Health Scholar
More informationChanges, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS
Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS Learning Objectives 1. Be able to describe the characteristics of brain injury 2.
More informationPlace of tumor bed radiosurgery and focal radiotherapy following resec7on of brain metastases: A new paradigm Lucyna Kepka
Place of tumor bed radiosurgery and focal radiotherapy following resec7on of brain metastases: A new paradigm Lucyna Kepka Department of Radia7on Oncology; M. Sklodowska- Curie Memorial Cancer Center and
More informationWho is at risk? What should we do in the clinic?
Cognitive Changes after Cancer Treatment Patricia A. Ganz, M.D. Professor, UCLA Schools of Medicine & Public Health Director, UCLA-LIVESTRONG Survivorship Center of Excellence Jonsson Comprehensive Cancer
More informationProphylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010
Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010 Outline Epidemiology Risk-groups Background & Rationale
More informationFATIGUE: PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT. Fausto Roila Medical Oncology Division, Terni, Italy
FATIGUE: PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT Fausto Roila Medical Oncology Division, Terni, Italy CONFLICT OF INTERESTS NO CONFLICT FATIGUE: DEFINITION (ASCO, NCCN) Cancer-related fatigue
More informationCurrent Approaches for Limited Small Cell Lung Cancer. Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver
Current Approaches for Limited Small Cell Lung Cancer Laurie Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver Can we improve or personalize treatment? Limited Histology/molecular
More informationCOGNITIVE AND BRAIN CHANGES IN MULTIPLE SCLEROSIS
1 COGNITIVE AND BRAIN CHANGES IN MULTIPLE SCLEROSIS MARCH 27, 2017 Esther Fujiwara, Ph.D. (efujiwara@ualberta.ca) Department of Psychiatry, University of Alberta 2 Objectives 1. Identify cognitive challenges
More informationChapter 7. Discussion and impact
Chapter 7 Discussion and impact 225 Affective pathology is a complex construct which encompasses a pathological disturbance in primary emotions, rapidly shifting from neutral to intense perception, associated
More informationCerebel trial Any impact on the clinical practice? Antonio Frassoldati Oncologia Clinica - Ferrara
Cerebel trial Any impact on the clinical practice? Antonio Frassoldati Oncologia Clinica - Ferrara CNS metastases in HER2+ BC The proportion of patients with HER2+ advanced breast cancer who have CNS metastases
More informationAdvances in Radiation Therapy
Advances in Radiation Therapy 2017 Recent Advances in Oncology Michelle Alonso-Basanta, MD PhD Helene Blum Assistant Professor Associate Chief of Clinical Operations Director of Quality Assurance Chief,
More informationOligometastatic Disease
Oligometastatic Disease Fact or Fantasy? Jennifer R Bellon MD, FASTRO Dana-Farber Cancer Institute Harvard Medical School Alexander V Louie MD PhD, FRCPC London Health Sciences Center Western University
More informationSurvival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery
ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.
More informationChemo Fog. Ottawa Lymphoma Support Group February 5, Barbara Collins, Ph. D., C. Psych. The Ottawa Hospital
Chemo Fog Ottawa Lymphoma Support Group February 5, 2013 Barbara Collins, Ph. D., C. Psych. The Ottawa Hospital Chemo Fog Devlen et al., 1987 (Br Med J 295:953-957) Surveyed patients with Hodgkin s disease
More informationDiagnosis and Treatment of Alzhiemer s Disease
Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised
More informationWelcome! South Central Chapter Annual Meeting & Research Update. December 2, 2015
Welcome! South Central Chapter Annual Meeting & Research Update December 2, 2015 Annual Meeting & Research Update Society Impact Annual Meeting & Research Update Board of Trustees, Finance Committee Financial
More informationNeurocognitive Assessment in Patients with Brain Metastases. Martin Klein VU University Medical Center Amsterdam, The Netherlands
Neurocognitive Assessment in Patients with Brain Metastases Martin Klein VU University Medical Center Amsterdam, The Netherlands Treatment Outcomes I Traditional/primary endpoints of efficacy:! Physician
More informationNEUROPLASTICITY. Implications for rehabilitation. Genevieve Kennedy
NEUROPLASTICITY Implications for rehabilitation Genevieve Kennedy Outline What is neuroplasticity? Evidence Impact on stroke recovery and rehabilitation Human brain Human brain is the most complex and
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationIVC History, Cancer Research
Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 81-116) Cytokine Signaling Categories Heal the Wound! Angiogenesis - 62 Inflammation - 69 Differentiation - 53 Oncogene-Activation -
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationS L I D E 0 S L I D E 1 S L I D E 2
AAPM Safety Certificate Course The Quality Gap Lessons Learned: Clinical Trials and Operations Smilow Cancer Hospital, Yale University Department of Therapeutic Radiology Sue Evans, MD, MPH Associate Professor
More informationNRG Publications Committee. Chair: Deborah Watkins Bruner, PhD Co-chairs: Elizabeth Gore, MD Thomas Julian, MD Krish Tewari, MD
NRG Publications Committee Chair: Deborah Watkins Bruner, PhD Co-chairs: Elizabeth Gore, MD Thomas Julian, MD Krish Tewari, MD NRG Abstract and Manuscript Submissions 161 Manuscripts 105 Publications in
More informationRisk Factors Associated with Cognitive Aging. Andrea Z. LaCroix, PhD. for the IOM Committee on the Public Health Dimensions of Cognitive Aging
Risk Factors Associated with Cognitive Aging Andrea Z. LaCroix, PhD. for the IOM Committee on the Public Health Dimensions of Cognitive Aging Lifestyle and Physical Environment Risk & Protective Factors
More informationCOGNITIVE REHABILITATION OF INDIVIDUALS WITH MS CMSC 2015
COGNITIVE REHABILITATION OF INDIVIDUALS WITH MS CMSC 2015 Aaron Turner, Ph.D. (ABPP-RP) Director, Rehabilitation Psychology VA Puget Sound Health Care System Associate Professor Department of Rehabilitation
More informationWHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
More informationCognitive Changes Associated with Cancer and Its Treatments: Current Knowledge and Challenges
Cognitive Changes Associated with Cancer and Its Treatments: Current Knowledge and Challenges Tim A. Ahles, Ph.D. Department of Psychiatry and Behavioral Sciences Neurocognitive Research Lab Memorial Sloan-Kettering
More informationPiecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder
Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives
More informationBackground CPX-351. Lancet J, et al. J Clin Oncol. 2017;35(suppl): Abstract 7035.
Overall Survival (OS) With Versus in Older Adults With Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia (taml): Subgroup Analysis of a Phase 3 Study Abstract 7035 Lancet JE, Rizzieri D, Schiller
More informationThe ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
More informationRadiotherapy of Brain Metastases and Carcinomatous Meningitis
Universitätsspital Basel Radiotherapy of Brain Metastases and Carcinomatous Meningitis Dr. J. Winkler 16.01.2009 1 in 4 cancer patients develop brain metastases In 1/3-1/2 of these patients brain metastasis
More informationDebate 1 Are treatments for small cell lung cancer getting better? No:
Debate 1 Are treatments for small cell lung cancer getting better? No: Taofeek Owonikoko, MD, PhD Associate Professor Department of Hematology & Medical Oncology Winship Cancer Institute of Emory University
More informationAblative Radiation Therapy For Inoperable Cholangiocarcinoma. Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology
Ablative Radiation Therapy For Inoperable Cholangiocarcinoma Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology Facts about radiation treatment High doses (2x the
More informationStandard care plan for Prophylactic Cranial Irradiation for Limited Stage (stage I-III) Small Cell Lung Cancer (25Gy in 10 fractions) References
CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Prophylactic Cranial Irradiation for Limited-stage Small Cell Lung Cancer (20Gy in 5 fractions) Clinical Guideline Standard Care
More informationLifestyle Risk Factors and Cancer Prevention
February 3-5, 2016 Lansdowne Resort, Leesburg, VA Lifestyle Risk Factors and Cancer Prevention Melinda L. Irwin, PhD, MPH Professor of Epidemiology, Yale School of Public Health, Associate Director (Population
More informationJ Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION
VOLUME 22 NUMBER 1 JANUARY 1 2004 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T From the M.D. Anderson Cancer Center, Houston, TX; Pharmacyclics Inc, Sunnyvale; California Cancer Care, Greenbrae,
More informationWomen s Wellness Day 2017
Women s Wellness Day 2017 Precision Medicine The Latest Tests for Detecting Wellness Michael Palladino, ND Rowena Daly, ND Travis Nesbit, MD Ailin Barseghian El-Farra, MD Functional Diagnostics for the
More informationHigh Risk Localized Prostate Cancer Treatment Should Start with RT
High Risk Localized Prostate Cancer Treatment Should Start with RT Jason A. Efstathiou, M.D., D.Phil. Assistant Professor of Radiation Oncology Massachusetts General Hospital Harvard Medical School 10
More informationAn update on radiation therapy for brain metastases
Review Article Page 1 of 8 An update on radiation therapy for brain metastases Tai-Chung Lam 1, Arjun Sahgal 2, Simon S. Lo 3, Eric L. Chang 4 1 Department of Clinical Oncology, Li Ka Shing Faculty of
More informationThe Role of Cardiovascular Risk and Aging in Memory Performance in a Sample of Veterans with HIV
The Role of Cardiovascular Risk and Aging in Memory Performance in a Sample of Veterans with HIV LYNN KAKOS, PH.D. VA MARYLAND HEALTH CARE SYSTEM (VAMHCS) OBJECTIVES HIV in the VA Neurocognitive profile
More informationThierry M. Muanza, MSc, MD, FRCPC,, McGill University Segal Cancer Centre, Jewish General Hospital Montreal, QC, Canada
Thierry M. Muanza, MSc, MD, FRCPC,, McGill University Segal Cancer Centre, Jewish General Hospital Montreal, QC, Canada Déclarations Aucun conflit d intérêt Objectifs d apprentissage Évolution de la radiothérapie
More informationFour Birds with One Stone Reparative, neuroplastic, cardiorespiratory and metabolic benefits of aerobic exercise post-stroke
Four Birds with One Stone Reparative, neuroplastic, cardiorespiratory and metabolic benefits of aerobic exercise post-stroke Michelle Ploughman BSc.PT, MSc., PhD Canada Research Chair (Tier II); Rehabilitation,
More information